top of page

Pipeline

​

Dawah Pharmaceuticals Inc. is advancing global healthcare through a robust pipeline of essential drugs in collaboration with top-tier international Contract Manufacturing Organizations (CMOs). By leveraging strategic overseas partnerships, we ensure the efficient delivery of FDA-compliant drugs that address critical therapeutic needs across a wide range of disease states.

​

Therapeutic Classifications and Disease States
​
Sterile Injectables
  • Antipsychotics: Supporting chronic and acute mental health conditions.

  • Paralytics: Facilitating anesthesia and patient stabilization in surgical and critical care settings.

  • Antibiotics: Combating severe bacterial infections, including resistant strains.

  • Oncology Drugs: Addressing various cancers with innovative and life-saving treatments.

  • Antifungals: Treating systemic and invasive fungal infections.

​

Ophthalmics
  • Anti-inflammatory Agents: Reducing inflammation in ocular diseases.

  • Antibiotic-Corticosteroid Combinations: Treating bacterial infections with concurrent inflammation.

  • Antihistamines: Providing relief from allergic conjunctivitis and related ocular allergies.

​

IV Bags and Total Parenteral Nutrition (TPN)
  • Pain Management: Offering intravenous acetaminophen for effective pain and fever control.

  • Critical Care Solutions: Including dopamine and electrolytes for emergency and intensive care applications.

  • Nutritional Support: High-use TPN formulations for patients with impaired oral intake.

​

Overseas Partnerships

Dawah Pharmaceuticals has meticulously evaluated over 30 global CMOs and strategically partnered with two industry leaders based overseas. These partnerships are integral to our operations, allowing us to:

  • Optimize manufacturing costs with contributions of the sterile production cost by our selected CMOs.

  • Expedite the production and regulatory approval processes for our pipeline drugs.

​

Key Activities Provided by CMOs
  1. Comprehensive Development: Formulation, process design, and analytical testing.

  2. Regulatory Preparedness: Manufacturing registration batches and compiling FDA dossiers.

  3. Stability Testing: Ensuring efficacy and safety over extended periods.

​

Commitment to Excellence

Our partnerships empower Dawah Pharmaceuticals to maintain agility while delivering high-quality, FDA-compliant drugs to address critical healthcare needs. By continuously assessing market trends and patient requirements, we are committed to expanding our pipeline and improving global access to essential medications.

© 2025 Dawah Pharmaceuticals Inc.

  • Facebook Social Icon
bottom of page